Key facts
- Notable investors include Lightbank (Venture Capital), MIT Solve, O'Leary Ventures, CHAP Health Ventures, Harvard HealthLab Accelerators.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Laptis
- ·The full record, as it builds
Funding rounds
No funding rounds for Laptis are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Laptis
Developer of a digital healthcare platform designed to streamline access to trusted substance use treatment for clinicians, lawyers and care navigators. The company's platform utilizes advanced algorithms to identify compatible treatment centers based on specific client needs and provides real-time bed availability information to expedite the search and placement process, enabling frontline clinicians, care navigators and lawyers to find the right substance use disorder treatment options for their clients.
- Sector
- Healthcare
- HQ
- Cambridge, MA, United States
- Founded
- 2023
- Employees
- 10
- Website
- laptis.io/
- Ownership
- Privately Held (backing)
Laptis doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Laptis shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Laptis in its N-PORT filings yet. We sweep new filings monthly.